31.93
price down icon0.53%   -0.17
after-market Dopo l'orario di chiusura: 32.00 0.07 +0.22%
loading

Immunocore Holdings Plc Adr Borsa (IMCR) Ultime notizie

pulisher
11:54 AM

Immunocore (IMCR) Q2 Revenue Jumps 30% - The Motley Fool

11:54 AM
pulisher
09:30 AM

Compared to Estimates, Immunocore (IMCR) Q2 Earnings: A Look at Key Metrics - Yahoo Finance

09:30 AM
pulisher
07:15 AM

Immunocore Holdings earnings missed by $0.02, revenue topped estimates - Investing.com

07:15 AM
pulisher
Aug 06, 2025

Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut - Yahoo Finance

Aug 06, 2025
pulisher
Aug 05, 2025

TGTX Down as Q2 Earnings Miss Mark, Briumvi Sales Drive Top Line - sharewise.com

Aug 05, 2025
pulisher
Jul 31, 2025

Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises - Barchart.com

Jul 31, 2025
pulisher
Jul 31, 2025

Immunocore to Report Q2 2025 Financial Results on August 7, 2025 - AInvest

Jul 31, 2025
pulisher
Jul 27, 2025

Analysts Set Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) PT at $58.89 - Defense World

Jul 27, 2025
pulisher
Jul 24, 2025

Wall Street Analysts See a 72.34% Upside in Immunocore (IMCR): Can the Stock Really Move This High? - Yahoo Finance

Jul 24, 2025
pulisher
Jul 24, 2025

The IMCR Stock Puzzle: Unraveling Immunocore Holdings plc ADR’s Fluctuating Performance - investchronicle.com

Jul 24, 2025
pulisher
Jul 24, 2025

Can Mizuho Financial Group, Inc. ADR Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Jul 24, 2025
pulisher
Jul 13, 2025

Principal Financial Group Inc. Reduces Stock Holdings in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) - Defense World

Jul 13, 2025
pulisher
Jul 08, 2025

MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy - sharewise.com

Jul 08, 2025
pulisher
Jul 08, 2025

COGT Stock Soars on Phase III Systemic Mastocytosis Study Success - sharewise.com

Jul 08, 2025
pulisher
Jul 02, 2025

Apellis Stock Rises On $300M Royalty Deal With Sobi For Aspaveli - Barchart.com

Jul 02, 2025
pulisher
Jul 01, 2025

Oppenheimer Asset Management Inc. Makes New Investment in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) - Defense World

Jul 01, 2025
pulisher
Jun 24, 2025

Wall Street Analysts See an 114.35% Upside in Immunocore (IMCR): Can the Stock Really Move This High? - MSN

Jun 24, 2025
pulisher
Jun 14, 2025

Immunocore’s SWOT analysis: stock outlook amid pipeline progress, market challenges By Investing.com - Investing.com South Africa

Jun 14, 2025
pulisher
Jun 14, 2025

Immunocore’s SWOT analysis: stock outlook amid pipeline progress, market challenges - Investing.com India

Jun 14, 2025
pulisher
Jun 11, 2025

Brokers Set Expectations for Immunocore FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

GAMMA Investing LLC Boosts Stock Position in Immunocore Holdings plc (NASDAQ:IMCR) - Defense World

Jun 10, 2025
pulisher
Jun 05, 2025

Immunocore at Jefferies Global Healthcare Conference: Strong Growth and Promising Trials - Investing.com India

Jun 05, 2025
pulisher
Jun 03, 2025

H.C. Wainwright reiterates buy rating on Immunocore stock amid ASCO update - Investing.com

Jun 03, 2025
pulisher
Jun 02, 2025

Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet - sharewise

Jun 02, 2025
pulisher
May 27, 2025

Deutsche Bank sets $65 target on Immunocore stock, rates Buy - Investing.com

May 27, 2025
pulisher
May 27, 2025

Deutsche Bank sets $65 target on Immunocore stock, rates Buy By Investing.com - Investing.com India

May 27, 2025
pulisher
May 26, 2025

Immunocore’s SWOT analysis: biotech firm’s stock faces challenges amid growth - Investing.com India

May 26, 2025
pulisher
May 24, 2025

Is it a Good Idea to Invest in Immunocore Stock Right Now? - MSN

May 24, 2025
pulisher
May 09, 2025

Balance Sheet Dive: Hippo Holdings Inc (HIPO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Analyzing Ratios: Symbotic Inc (SYM)’s Financial Story Unveiled - DWinneX

May 09, 2025
pulisher
May 08, 2025

New Strong Buy Stocks for May 8th - The Globe and Mail

May 08, 2025
pulisher
May 07, 2025

Immunocore stock rises as Q1 results top estimates By Investing.com - Investing.com South Africa

May 07, 2025
pulisher
May 07, 2025

Immunocore stock rises as Q1 results top estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

Immunocore Holdings earnings beat by $0.49, revenue topped estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

Compared to Estimates, Immunocore (IMCR) Q1 Earnings: A Look at Key Metrics - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

ESPR's Q1 Earnings Miss Estimates, Revenues Beat, Stock Down - Barchart.com

May 06, 2025
pulisher
May 06, 2025

AXSM Q1 Loss Narrower Than Expected, Auvelity Drives Revenues Y/Y - The Globe and Mail

May 06, 2025
pulisher
May 02, 2025

Agios' Q1 Loss Narrower Than Expected, Revenues Lag Estimates - Barchart.com

May 02, 2025
pulisher
Apr 30, 2025

Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y - Barchart.com

Apr 30, 2025
pulisher
Apr 30, 2025

Wall Street Analysts Think Immunocore (IMCR) Could Surge 107.45%: Read This Before Placing a Bet - Yahoo Finance

Apr 30, 2025
pulisher
Apr 07, 2025

Mizuho cuts Immunocore stock price target to $33 from $38 - Investing.com

Apr 07, 2025
pulisher
Apr 04, 2025

Immunocore stock hits 52-week low at $27.19 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Immunocore stock hits 52-week low at $27.19 amid market challenges - Investing.com

Apr 04, 2025
pulisher
Mar 28, 2025

Do investors need to be concerned about Immunocore Holdings plc ADR (IMCR)? - US Post News

Mar 28, 2025
pulisher
Mar 22, 2025

Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last? - MSN

Mar 22, 2025
pulisher
Mar 19, 2025

Immunocore holdings sees $23.99 million in stock purchases by Baker Bros - Investing.com South Africa

Mar 19, 2025
$78.20
price up icon 0.71%
$37.01
price down icon 0.30%
$109.30
price down icon 1.76%
$28.07
price down icon 1.58%
$111.35
price up icon 0.04%
biotechnology ONC
$298.29
price down icon 0.08%
Capitalizzazione:     |  Volume (24 ore):